In contrast, MRF/magnet without addition of an immunomodulatory therapy induced enhanced anti-tumor responses with increased tumor-infiltrating CD8(+) T cells and inhibition of outgrowth of metastatic breast cancer. The gene discussed is CD8A; the disease is neoplasm.